NASDAQ
Fulcrum Therapeutics, Inc. (FULC) has a free cash flow growth of -10.62% as of Friday, May 29, 2026. This represents a 1679.05% decrease compared to its 12-month average of -0.60%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.